BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15254439)

  • 1. Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C.
    Murphy MJ; Wilcox RD
    Am J Med Sci; 2004 Jul; 328(1):26-36. PubMed ID: 15254439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
    Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
    Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients].
    Toro Rueda C; Ramos Blázquez B; Soriano Vázquez V
    Enferm Infecc Microbiol Clin; 2006 Oct; 24 Suppl 1():30-5. PubMed ID: 17125666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatic complications in HIV-infected persons.
    Sulkowski MS
    J Infect Dis; 2008 May; 197 Suppl 3():S279-93. PubMed ID: 18447614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis B in patients coinfected with the human immunodeficiency virus.
    Lessells R; Leen C
    Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):366-74. PubMed ID: 15112069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and human immunodeficiency virus coinfections.
    Dodig M; Tavill AS
    J Clin Gastroenterol; 2001; 33(5):367-74. PubMed ID: 11606851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral hepatitis and HIV coinfection.
    Sulkowski MS
    J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
    J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Levy V; Grant RM
    Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral hepatitis B/C and HIV. Therapy of double infections].
    Mauss S
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Bani-Sadr F; Palmer P; Scieux C; Molina JM
    Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
    Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
    Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.